Full Text View
Tabular View
No Study Results Posted
Related Studies
The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD
This study has been completed.
Study NCT00163059.   Last updated on September 21, 2006.
Information provided by Pfizer
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Disorder, Major
Additional conditions recognized in this trial
Depression
Depressive Disorder
Disease
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Pathologic Processes
Additional drug interventions recognized in this trial
Antidepressive Agents
More general drug interventions related to this trial
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Pfizer


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services